| Primary |
| Rheumatoid Arthritis |
71.5% |
| Hypertension |
4.9% |
| Drug Use For Unknown Indication |
3.9% |
| Product Used For Unknown Indication |
2.4% |
| Psoriatic Arthropathy |
2.4% |
| Prophylaxis |
2.0% |
| Pain |
1.8% |
| Arthritis |
1.7% |
| Hypercholesterolaemia |
1.0% |
| Immunosuppression |
0.9% |
| Juvenile Arthritis |
0.9% |
| Asthma |
0.8% |
| Osteoporosis |
0.8% |
| Wound Infection |
0.8% |
| Atrial Fibrillation |
0.7% |
| Hypothyroidism |
0.7% |
| Constipation |
0.7% |
| Duodenal Ulcer |
0.7% |
| Seronegative Arthritis |
0.7% |
| Angina Pectoris |
0.6% |
|
| Drug Exposure During Pregnancy |
15.3% |
| Maternal Exposure During Pregnancy |
10.2% |
| Weight Decreased |
8.3% |
| Ischaemic Stroke |
5.6% |
| Progressive Multifocal Leukoencephalopathy |
5.6% |
| Dyspnoea |
5.1% |
| Vomiting |
5.1% |
| Hepatic Enzyme Increased |
4.6% |
| Renal Failure Acute |
4.2% |
| Hypertension |
3.7% |
| Liver Function Test Abnormal |
3.7% |
| Pyrexia |
3.7% |
| Off Label Use |
3.2% |
| Pancytopenia |
3.2% |
| Posterior Reversible Encephalopathy Syndrome |
3.2% |
| Pregnancy |
3.2% |
| Respiratory Failure |
3.2% |
| Sepsis |
3.2% |
| Hepatic Function Abnormal |
2.8% |
| Rash |
2.8% |
|
| Secondary |
| Rheumatoid Arthritis |
36.0% |
| Drug Use For Unknown Indication |
10.5% |
| Pain |
8.4% |
| Osteoporosis |
8.0% |
| Myalgia |
7.5% |
| Hypermobility Syndrome |
7.3% |
| Osteoarthritis |
7.3% |
| Product Used For Unknown Indication |
5.5% |
| Juvenile Arthritis |
2.3% |
| Psoriatic Arthropathy |
1.5% |
| Hypertension |
1.5% |
| Asthma |
0.7% |
| Arthritis |
0.6% |
| Juvenile Idiopathic Arthritis |
0.5% |
| Prophylaxis |
0.5% |
| Renal Transplant |
0.5% |
| Type 2 Diabetes Mellitus |
0.4% |
| Diabetes Mellitus |
0.4% |
| Ankylosing Spondylitis |
0.3% |
| Cytomegalovirus Viraemia |
0.3% |
|
| Suicidal Ideation |
34.0% |
| Weight Decreased |
5.8% |
| Wound Infection Staphylococcal |
4.9% |
| Pneumonia |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Vomiting |
4.5% |
| Tubulointerstitial Nephritis |
3.9% |
| Thrombocytopenia |
3.6% |
| Drug Hypersensitivity |
3.2% |
| Myocardial Infarction |
3.2% |
| Overdose |
3.2% |
| Sepsis |
3.2% |
| Hodgkin's Disease |
2.9% |
| Weight Increased |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Wound Infection |
2.9% |
| Pyrexia |
2.6% |
| Respiratory Failure |
2.6% |
| Hypertension |
2.3% |
| Joint Instability |
2.3% |
|
| Concomitant |
| Rheumatoid Arthritis |
40.4% |
| Drug Use For Unknown Indication |
21.6% |
| Product Used For Unknown Indication |
18.8% |
| Hypertension |
4.4% |
| Pain |
2.5% |
| Psoriatic Arthropathy |
2.0% |
| Osteoporosis |
1.8% |
| Arthritis |
1.3% |
| Diabetes Mellitus |
1.1% |
| Depression |
0.9% |
| Vitamin Supplementation |
0.7% |
| Hypothyroidism |
0.6% |
| Asthma |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Psoriasis |
0.5% |
| Blood Pressure |
0.5% |
| Insomnia |
0.5% |
| Prophylaxis |
0.4% |
| Blood Cholesterol Increased |
0.4% |
| Ankylosing Spondylitis |
0.4% |
|
| Rheumatoid Arthritis |
12.8% |
| Injection Site Pain |
10.9% |
| Vomiting |
7.5% |
| Weight Decreased |
5.9% |
| Urinary Tract Infection |
5.7% |
| Pneumonia |
5.1% |
| Pain |
5.0% |
| Pain In Extremity |
4.4% |
| Injection Site Swelling |
4.4% |
| Sinusitis |
4.4% |
| Drug Ineffective |
4.3% |
| Rash |
4.1% |
| Pyrexia |
3.8% |
| Sepsis |
3.7% |
| Myocardial Infarction |
3.5% |
| Arthralgia |
3.2% |
| Staphylococcal Infection |
3.2% |
| Death |
3.1% |
| Diarrhoea |
2.7% |
| Weight Increased |
2.6% |
|
| Interacting |
| Rheumatoid Arthritis |
37.9% |
| Drug Use For Unknown Indication |
27.2% |
| Juvenile Arthritis |
6.8% |
| Hypertension |
4.9% |
| Atrial Fibrillation |
2.9% |
| Embolism Arterial |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Obstructive Airways Disorder |
1.9% |
| Osteoporosis |
1.9% |
| Pain |
1.9% |
| Blood Cholesterol |
1.0% |
| Colitis Ulcerative |
1.0% |
| Crohn's Disease |
1.0% |
| Depression |
1.0% |
| Hyperchlorhydria |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Pulmonary Fibrosis |
1.0% |
| Thyroid Disorder |
1.0% |
| Vitamin D Decreased |
1.0% |
|
| Respiratory Tract Infection |
19.2% |
| Drug Interaction |
15.4% |
| Pneumonia Legionella |
11.5% |
| Tardive Dyskinesia |
11.5% |
| Pain |
7.7% |
| Red Blood Cell Count Decreased |
7.7% |
| Abdominal Distension |
3.8% |
| Arthritis |
3.8% |
| Meningitis |
3.8% |
| Neuropathy Peripheral |
3.8% |
| Sensory Disturbance |
3.8% |
| Transaminases Increased |
3.8% |
| Urticaria |
3.8% |
|
